Naloxone-induced electrographic seizures in the primate

Area of Science:

• Neuroscience
• Pharmacology
• Primate Research

Background:

• Methadone is an opioid agonist used for pain management and opioid use disorder treatment.
• Naloxone is an opioid antagonist used to reverse opioid overdose.
• High methadone concentrations can lead to significant physiological effects.

Purpose of the Study:

• To investigate the effects of naloxone administration in methadone-treated, artificially ventilated macaques.
• To determine if naloxone exhibits epileptogenic properties in the presence of high methadone levels.
• To assess naloxone's antagonistic properties against methadone-induced electroencephalographic activity.

Main Methods:

• Electrographic seizure activity was monitored in artificially ventilated, methadone-treated stump-tailed macaques following naloxone injection.
• Plasma-methadone concentrations were measured.
• Control animals without methadone pretreatment were also studied.

Main Results:

• Seizure activity was observed shortly after naloxone injection in methadone-treated macaques.
• Pre-injection plasma-methadone concentrations were significantly higher than levels causing respiratory depression in non-ventilated animals.
• Seizure duration correlated with naloxone dosage, and naloxone was not epileptogenic in non-methadone-treated animals.
• Naloxone did not antagonize methadone-induced electroencephalographic spiking.

Conclusions:

• Methadone and naloxone exhibit additive epileptogenic properties at high plasma-methadone concentrations in artificially ventilated primates.
• Naloxone lacks antagonistic effects on methadone-induced electroencephalographic spiking.
• These findings highlight potential risks of naloxone administration in individuals with high opioid burdens.